Search - tctmd.com

Displaying 21 - 40 of 284

Sort: Relevancy | Date

Presentation THT 2025

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Presenter: Josephine Harrington

February 11, 2025

Presentation THT 2025

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Presenter: Mark Petrie

February 11, 2025

Presentation TCT 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presenter: James Min

October 30, 2024

Presentation TCT 2024

Creative Uses of AI in Imaging for Structural Heart Disease

Presenter: Partho Sengupta

October 30, 2024

Presentation TCT 2024

TCT 13: Chinese Visceral Adiposity Index Is Associated With the Occurrence of Cardiovascular Disease Among Middle-Aged and Older People in China

Presenter: Rongchong Huang

October 29, 2024

Presentation TCT 2024

TCT 240: The Device Success Algorithm of EAPCI Prospectively Applied to the Three-Vessel Coronary Artery Disease Patients Undergoing State-of-the-Art Percutaneous Coronary Intervention in International Multivessel TALENT Randomized Trial

Presenter: Pruthvi C Revaiah

October 28, 2024

Presentation TCT 2024

TCT 292: Prognostic Value of Quantitative Flow Ratio in Patients Undergoing Primary Valve Surgery Combined With Coronary Artery Disease

Presenter: Chenguang Li

October 28, 2024

Presentation TCT 2024

TCT 290: Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the SWEDEHEART Registry

Presenter: Elmir Omerovic

October 28, 2024

Presentation TCT 2024

Wound Care Transition – Holistic Care for Transition from Inpatient to Outpatient

Presenter: Kimberly Campbell

October 27, 2024

Presentation TCT 2024

Its "Just a Peripheral" - Wrong! Addressing Complications and How to Manage as a CV Team

Presenter: Kenzie Thompson

October 27, 2024

Presentation TCT 2024

New Interventional Approaches to CLTI - DVA and Bioabsorbable

Presenter: Matthew Bunte

October 27, 2024

Presentation TCT 2024

GDMT for PAD to Include Diabetes and Nutrition

Presenter: Bailey Estes

October 27, 2024

Presentation TCT 2024

TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft

Presenter: IFTIKHAR CH

October 27, 2024

Presentation TCT 2024

How to Recognize Amyloidosis and the Consequences of the Disease?

Presenter: Joban Vaishnav

October 27, 2024

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

Presentation ACC 2024

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Presenter: Eric Quinton Klug

April 07, 2024

Presentation ACC 2024

Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial

Presenter: Michael J. Koren

April 06, 2024

Presentation Controversies and Advances 2023

Obesity and Cardiovascular Disease

Presenter: Steven E. Nissen

November 30, 2023

Presentation TCT 2023

TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy

Presenter: Jung-Hee Lee

October 25, 2023

Advertisement

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Creative Uses of AI in Imaging for Structural Heart Disease

TCT 13: Chinese Visceral Adiposity Index Is Associated With the Occurrence of Cardiovascular Disease Among Middle-Aged and Older People in China

TCT 240: The Device Success Algorithm of EAPCI Prospectively Applied to the Three-Vessel Coronary Artery Disease Patients Undergoing State-of-the-Art Percutaneous Coronary Intervention in International Multivessel TALENT Randomized Trial

TCT 292: Prognostic Value of Quantitative Flow Ratio in Patients Undergoing Primary Valve Surgery Combined With Coronary Artery Disease

TCT 290: Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the SWEDEHEART Registry

Wound Care Transition – Holistic Care for Transition from Inpatient to Outpatient

Its "Just a Peripheral" - Wrong! Addressing Complications and How to Manage as a CV Team

New Interventional Approaches to CLTI - DVA and Bioabsorbable

GDMT for PAD to Include Diabetes and Nutrition

TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft

How to Recognize Amyloidosis and the Consequences of the Disease?

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial

Obesity and Cardiovascular Disease

TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content